SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-04-007381
Filing Date
2004-03-15
Accepted
2004-03-15 12:23:59
Documents
6
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a04-3283_110k.htm 10-K 1291722
3 EX-14.0 a04-3283_1ex14d0.htm EX-14.0 84279
4 EX-23.0 a04-3283_1ex23d0.htm EX-23.0 4694
5 EX-31.1 a04-3283_1ex31d1.htm EX-31.1 10977
6 EX-31.2 a04-3283_1ex31d2.htm EX-31.2 10205
7 EX-32.0 a04-3283_1ex32d0.htm EX-32.0 7243
  Complete submission text file 0001104659-04-007381.txt   1411283
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14895 | Film No.: 04668472
SIC: 2834 Pharmaceutical Preparations